Find this article useful?
Why not sign up to our mailing list and receive regular articles and tips about IBD to your inbox.
In this article we take a look at OptiBac probiotics and IBD.
OptiBac Probiotics are freeze-dried probiotic supplement capsules and sachets. There are 11 different types of OptiBac Probiotics supplements which each have different strains of live cultures in them to target different things. They come in capsules and sachets (which can be taken directly or mixed with food/water). They are all gluten and dairy free.
OptiBac Probiotics suggests two of their supplements for people with IBD (which can be taken together) - For every day EXTRA Strength and Saccharomyces boulardii. If you have constipation then Bifidobacteria & fibre is recommended.
For every day EXTRA Strength capsules contains bacteria strains:
Its other ingredients include:
OptiBac says 20 billion micro-organisms are guaranteed in each capsule
Saccharomyces boulardii capsules contains bacteria strains:
Its other ingredients include:
OptiBac says 5 billion live cultures are guaranteed in each capsule
Bifidobacteria & fibre sachets contains bacteria strains:
Its other ingredients include:
OptiBac says 5 billion micro-organisms + 4g FOS fibres are guaranteed in each sachet.
OptiBac Probiotics supplements come in either capsules or sachets (depending on the product) and should be taken with or before breakfast.
OptiBac Probiotics says their products:
When OptiBac Probiotics products are consumed the digestive system reactivates the live bacteria by adding moisture and warmth to 'wake’ them up. Once re-activated the bacteria then do their job as they move through the digestive tract.
OptiBac Probiotics has 11 different products which they have specifically created to target different needs. The bacteria strains in each product have been selected to assist these health conditions based on available research. The viability and efficacy of the probiotic strains are also considered.
Their 11 products include:
There is no research specifically into OptiBac Probiotics products and IBD.
There is research into some of the strains OptiBac Probiotics include in their products and IBD, or IBD-related symptoms.
Saccharomyces boulardii - helps in the prevention of Crohn’s disease flare ups1 and in gaining remission for ulcerative colitis2. For Crohn’s disease results suggested that Saccharomyces boulardii may represent a useful tool in the maintenance treatment of Crohn’s disease. For ulcerative colitis the study’s preliminary results suggest that S. boulardii can be effective in the treatment of ulcerative colitis.
Bifidobacterium animalis subsp. lactis, BB-12 for constipation3. The results of the study strongly support a clinically relevant benefit of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort.
There is no research specifically into OptiBac Probiotics products and other bowel conditions.
There is research into strains OptiBac Probiotics uses in its products and irritable bowel syndrome (IBS).
Lactobacillus acidophilus NCFM and IBS4 - following this study patients noticed an improvement in bloating (73%), reduction in passage of excess gas (54%), decreased abdominal pain/cramps (62%), decrease in diarrhoea (62%), improvement of constipation (54%), decrease in alternating diarrhoea and constipation (58%) and decrease in sensation of incomplete evacuation (27%).
Lactobacillus acidophilus NCFM is included in OptiBac Probiotics’ Everyday extra strength product.
OptiBac Probiotics are sold by Wren Laboratories Ltd. The product is made for them by their chosen 3rd parties. Wren Laboratories Ltd are a family run business which started in 2004 by Feroze Janmohamed who was a community pharmacist for 35 years. The company is now run by his son Jalal.
OptiBac Probiotics products are manufactured by third parties across the world. Different bacteria strains are cultured in different places - including United States, Canada and France.
Each bacteria strain is classified and identified to ensure the strain claimed on the packet is the same as the strain in the product. The species in the products are all given certificates of qualified presumption of safety (QPS) which is a requirement of the European Food Safety Authority (EFSA). OptiBac says it also has full traceability of raw materials to the final product.
Bacterial cell counts are taken at each stage of manufacture, including a final count of the finished product. Studies have also been done which measure the number of bacteria in the products at various stages of its two-year shelf life. Each product at least matched the number of claimed bacteria on the packet and the actual number of bacteria in the product.
The amount of time and dosage depends on which of the OptiBac Probiotics products you take. Every Day Extra Strength, Saccharomyces boulardii and Bifidobacteria & fibre are all recommended for on-going use (ie daily).
OptiBac Probiotics products are recommended to be kept in a cool, dry place until the expiry date on the packet. They do not need to be kept in the fridge. OptiBac Probiotics say this reduces the chance of the bacteria degrading before being ingested.
The products have a two-year shelf life.
In the UK most probiotics are governed under the same laws as foods, not medicines, and governing bodies include the European Food Safety Authority (EFSA), the Food Safety Authority (FSA) and the Advisory Committee on Borderline Substances.
These bodies issue guidelines around what probiotic companies can say in relation to their product and health claims they can make. Even if a probiotic has medical evidence to support its use for a certain condition they cannot publicise this unless they go through strict medical testing - a very expensive and lengthy process.
This is why you will often find that probiotic companies do not mention specific health conditions on their website and marketing material. Guidelines have also been issued to say that the term probiotic may no longer be used in the promotion of supplements by the companies. The Advertising Standards Authority also has oversight regarding claims made and any complaints arising. In general, the industry is self-regulated so some companies choose to 'bend’ the rules around making health claims in relation to their product.
The cost depends on which product you take:
OptiBac Probiotics For Every Day Extra Strength: 90 capsules cost around £59.99. It is recommended you take one or two capsules daily - that’s 66p (one capsule) or £1.33 (two capsules) per day.
OptiBac Probiotics Saccharomyces boulardii: 80 capsules cost around £25.99. It is recommended you take one to four capsules a day - that’s between 32p (one capsule) and £1.30 (four capsules) per day.
OptiBac Probiotics Bifidobacteria & fibre: 30 sachets cost around £19.99. It is recommended you take one sachet daily, or up to four if required - that’s 66p (one sachet) and £2.66 (four sachets).
You can buy them directly from OptiBac's website*: www.optibacprobiotics.co.uk
*Please note these are affiliate links which means if you buy from the company we may receive a commission. You will pay the same price as you normally would and any money earned by us will be used to support IBDrelief's work.
Guslandi, M. et al. (2000) Saccharomyces boulardii in Maintenance Treatment of Crohn's Disease. Digestive Diseases & Sciences. Vol 45, 7, 1462 - 1464
Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003 Jun;15(6):697-8. PMID:12840682
Dorte Eskesen, Lillian Jespersen, Birgit Michelsen, Peter J. Whorwell, Stefan Müller-Lissner, and Cathrine M. Morberg. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015 Nov 28; 114(10): 16381646. PMCID: PMC4657032
Steven M Faber. Treatment of abnormal gut flora improves symptoms in patients with irritable bowel syndrome. The American Journal of Gastroenterology 95, 2533 (September 2000)
Why not sign up to our mailing list and receive regular articles and tips about IBD to your inbox?